Development of therapeutic medical countermeasures

  • Description
  • Details
  • Subprojects
  • History
  • Relations
  • Publications
Project Title: Development of therapeutic medical countermeasures
Project Number: 272201300019C-3-0-1
Project web address: Follow on NIH
Organization: Venatorx Pharmaceuticals, Inc., United States, Pennsylvania, MALVERN
Principal Investigators (PI): Xerri Luigi, US
 
Project Description:
This contract supports the advanced development of promising therapeutic candidates with broad spectrum activity. The research and development activities to be supported will allow candidate therapeutic products to progress through the product development pipeline, and includes preclinical and non-clinical activities, as well as IND development activities.
 
Project Terms:
advanced development bacterial drug resistance development gram-negative bacteria medical pre-clinical product development research and development support contracts therapeutic therapeutic development antimicrobial resistance biodefense emerging infectious diseases infectious diseases
Project Title: Development of therapeutic medical countermeasures
Project Number: 272201300019C-3-0-1
Project web address: Follow on NIH
Organization: Venatorx Pharmaceuticals, Inc., United States, Pennsylvania, MALVERN
Principal Investigators (PI): Xerri Luigi, US
 
Project Categories:
Natural Sciences > Clinical Trials & Therapy > Clinical trials
 
Other Information:
Fiscal Year: 2013
Project Start Date: 16 September 2013
Project End Date: 15 September 2016
 
Project Funding Information:
Funding Mechanism: Non SBIR/STTR Contracts
Year Funding Organization Total Funding, $
2015 NIH - National Institute Of Allergy And Infectious Diseases $9,361,587
Project Title: Development of therapeutic medical countermeasures
Project Number: 272201300019C-3-0-1
Project web address: Follow on NIH
Organization: Venatorx Pharmaceuticals, Inc., United States, Pennsylvania, MALVERN
Principal Investigators (PI): Xerri Luigi, US
 
Title FY Funding
There are no results for this project in database.
Project Title: Development of therapeutic medical countermeasures
Project Number: 272201300019C-3-0-1
Project web address: Follow on NIH
Organization: Venatorx Pharmaceuticals, Inc., United States, Pennsylvania, MALVERN
Principal Investigators (PI): Xerri Luigi, US
 
Project number Project title Principal investigator
There are no any related projects.
Project Title: Development of therapeutic medical countermeasures
Project Number: 272201300019C-3-0-1
Project web address: Follow on NIH
Organization: Venatorx Pharmaceuticals, Inc., United States, Pennsylvania, MALVERN
Principal Investigators (PI): Xerri Luigi, US
 
Title Journal Year Country Rel